374 related articles for article (PubMed ID: 33543443)
41. Long noncoding RNA CASC9 promotes the proliferation and metastasis of papillary thyroid cancer via sponging miR-488-3p.
Chen Y; Li Y; Gao H
Cancer Med; 2020 Mar; 9(5):1830-1841. PubMed ID: 31943867
[TBL] [Abstract][Full Text] [Related]
42. MicroRNA-146b promotes PI3K/AKT pathway hyperactivation and thyroid cancer progression by targeting PTEN.
Ramírez-Moya J; Wert-Lamas L; Santisteban P
Oncogene; 2018 Jun; 37(25):3369-3383. PubMed ID: 29353884
[TBL] [Abstract][Full Text] [Related]
43. Single-cell and bulk RNA sequencing reveal heterogeneity and diagnostic markers in papillary thyroid carcinoma lymph-node metastasis.
Lu DN; Zhang WC; Lin YZ; Jiang HY; He R; Li SL; Zhang YN; Shao CY; Zheng CM; Xu JJ; Ge MH
J Endocrinol Invest; 2024 Jun; 47(6):1513-1530. PubMed ID: 38146045
[TBL] [Abstract][Full Text] [Related]
44. Long non-coding RNA DLEUI promotes papillary thyroid carcinoma progression by sponging miR-421 and increasing ROCK1 expression.
Li R; Wan T; Qu J; Yu Y; Zheng R
Aging (Albany NY); 2020 Sep; 12(20):20127-20138. PubMed ID: 32910787
[TBL] [Abstract][Full Text] [Related]
45. LINC00641 impeded the malignant biological behaviors of papillary thyroid carcinoma cells via interacting with IGF2BP1 to reduce GLI1 mRNA stability.
Meng D; Zhao S; Wu L; Ma X; Zhao D; Li Z
Hum Exp Toxicol; 2023; 42():9603271231180856. PubMed ID: 37291850
[TBL] [Abstract][Full Text] [Related]
46. Therapeutic targeting of TNIK in papillary thyroid carcinoma: a novel approach for tumor growth suppression.
Zhang R; Yu Y; Yang Y; Zhang M; Zhang X; Chang Y; Wang S; Hu L; Li J; Zheng X; Zhao R; Guo Y; Ni X
Med Oncol; 2024 May; 41(6):160. PubMed ID: 38763968
[TBL] [Abstract][Full Text] [Related]
47. Circular RNA hsa_circ_0001666 sponges miR‑330‑5p, miR‑193a‑5p and miR‑326, and promotes papillary thyroid carcinoma progression via upregulation of ETV4.
Qi Y; He J; Zhang Y; Wang L; Yu Y; Yao B; Tian Z
Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33760216
[TBL] [Abstract][Full Text] [Related]
48. High expression of LINC0163 promotes progression of papillary thyroid cancer by regulating epithelial-mesenchymal transition MITF.
Gao P; Jiao H; Zhe L; Cui J
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5504-5511. PubMed ID: 32495885
[TBL] [Abstract][Full Text] [Related]
49. PDLIM7 Promotes Tumor Metastasis in Papillary Thyroid Carcinoma via Stabilizing Focal Adhesion Kinase Protein.
Yang F; Yang M; Liu Y; Zhou C; Chen Y; Wu J; Zhang X; Xiao S
Thyroid; 2024 May; 34(5):598-610. PubMed ID: 38243825
[No Abstract] [Full Text] [Related]
50. Upregulation of lncRNA-ATB by Transforming Growth Factor β1 (TGF-β1) Promotes Migration and Invasion of Papillary Thyroid Carcinoma Cells.
Cui M; Chang Y; Du W; Liu S; Qi J; Luo R; Luo S
Med Sci Monit; 2018 Jul; 24():5152-5158. PubMed ID: 30042377
[TBL] [Abstract][Full Text] [Related]
51. Circ_PSD3 promotes the progression of papillary thyroid carcinoma via the miR-637/HEMGN axis.
Li Z; Huang X; Liu A; Xu J; Lai J; Guan H; Ma J
Life Sci; 2021 Jan; 264():118622. PubMed ID: 33203523
[TBL] [Abstract][Full Text] [Related]
52. Silencing of long noncoding RNA RP11-476D10.1 enhances apoptosis and autophagy while inhibiting proliferation of papillary thyroid carcinoma cells via microRNA-138-5p-dependent inhibition of LRRK2.
Zhao Y; Zhao L; Li J; Zhong L
J Cell Physiol; 2019 Nov; 234(11):20980-20991. PubMed ID: 31102261
[TBL] [Abstract][Full Text] [Related]
53. IMP3 accelerates the progression of prostate cancer through inhibiting PTEN expression in a SMURF1-dependent way.
Zhang X; Wang D; Liu B; Jin X; Wang X; Pan J; Tu W; Shao Y
J Exp Clin Cancer Res; 2020 Sep; 39(1):190. PubMed ID: 32938489
[TBL] [Abstract][Full Text] [Related]
54. MicroRNA-222 Promotes Invasion and Metastasis of Papillary Thyroid Cancer Through Targeting Protein Phosphatase 2 Regulatory Subunit B Alpha Expression.
Huang Y; Yu S; Cao S; Yin Y; Hong S; Guan H; Li Y; Xiao H
Thyroid; 2018 Sep; 28(9):1162-1173. PubMed ID: 29882471
[TBL] [Abstract][Full Text] [Related]
55. Overexpression of long non-coding RNA LINC00982 suppresses cell proliferation and tumor growth of papillary thyroid carcinoma through PI3K-ATK signaling pathway.
Xu D; Yu J; Zhuang S; Zhang S; Hong Z; Yuan C
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31262968
[TBL] [Abstract][Full Text] [Related]
56. Expression and Function of Long Noncoding RNA NONHSAT129183 in Papillary Thyroid Cancer.
Ding J; Wang F; Xiang T; Qiao M
Oncol Res; 2018 Aug; 26(7):1047-1053. PubMed ID: 29321094
[TBL] [Abstract][Full Text] [Related]
57. LncRNA GAS8-AS1 suppresses papillary thyroid carcinoma cell growth through the miR-135b-5p/CCND2 axis.
Chen N; Yin D; Lun B; Guo X
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30429236
[TBL] [Abstract][Full Text] [Related]
58. MicroRNA-31 inhibits papillary thyroid carcinoma cell biological progression by directly targeting SOX11 and regulating epithelial-to-mesenchymal transition, ERK and Akt signaling pathways.
Wang Y; Liu BG; Zhou CX
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5863-5873. PubMed ID: 31298337
[TBL] [Abstract][Full Text] [Related]
59. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
Lu C; Shan Z; Hong J; Yang L
Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
[TBL] [Abstract][Full Text] [Related]
60. LncRNA ENST00000539653 acts as an oncogenic factor via MAPK signalling in papillary thyroid cancer.
Song B; Li R; Zuo Z; Tan J; Liu L; Ding D; Lu Y; Hou D
BMC Cancer; 2019 Apr; 19(1):297. PubMed ID: 30940124
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
